$106.45 0.00 (%) Gilead Sciences Inc - NASDAQ

Sep. 30, 2014 | 04:00 PM

Partner Headlines

  1. J&J Moves Into Gilead's Turf

    IBD | Sep. 30, 2014 | 18:43PM EST
  2. J&J Buying Alios, Going Up Against Gilead

    IBD | Sep. 30, 2014 | 12:02PM EST
  3. Biotech Stocks Rebound On Strong Earnings, New Drugs

    IBD | Sep. 29, 2014 | 18:32PM EST
  4. Gilead Sciences, Inc. Consolidating Gains?

    Benzinga | Sep. 29, 2014 | 15:30PM EST
  5. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts | Sep. 29, 2014 | 08:15AM EST
  6. Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26

    Benzinga | Sep. 27, 2014 | 10:33AM EST
  7. Many IBD 50 Stocks Testing Key Support Level

    IBD | Sep. 26, 2014 | 19:09PM EST
  8. There's More to Gilead Sciences than a Successful Drug

    GuruFocus | Sep. 26, 2014 | 19:07PM EST
  9. IBD 50: Gilead's Sovaldi Drives Earnings Growth

    IBD | Sep. 26, 2014 | 19:03PM EST
  10. Can Gilead Sciences Be A Do-Gooder And Still Do Well?

    IBD | Sep. 26, 2014 | 14:37PM EST
  11. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  12. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  13. Gilead reports good HIV trial

    IBD | Sep. 24, 2014 | 18:14PM EST
  14. Gilead's New HIV Drug Key To Long-Term Strategy

    IBD | Sep. 24, 2014 | 17:29PM EST
  15. Acorda To Buy Civitas, Gains Parkinson's Disease Drug

    IBD | Sep. 24, 2014 | 13:27PM EST
  16. Gilead's Next-Gen HIV Drug Bests Stribild In Trials

    IBD | Sep. 24, 2014 | 12:04PM EST
  17. Most Big Cap 20 Stocks Near Entries, But Risks Exist

    IBD | Sep. 22, 2014 | 19:05PM EST
  18. IBD 50 Stocks Setting Up, Including These 5 Medicals

    IBD | Sep. 19, 2014 | 18:35PM EST
  19. Gilead's Zydelig Approved In EU; Imbruvica In Wings

    IBD | Sep. 19, 2014 | 12:17PM EST
  20. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Sep. 19, 2014 | 07:22AM EST
  21. 2 Columbia Growth Funds Notch Impressive Three-Month Performance

    Benzinga | Sep. 18, 2014 | 10:52AM EST
  22. Gilead Dips On Drug Setbacks

    IBD | Sep. 17, 2014 | 19:23PM EST
  23. Gilead Stock Is Falling On These Drug Setbacks

    IBD | Sep. 17, 2014 | 12:52PM EST
  24. This Top Growth Fund Leans Heavily On Large-Cap Tech

    Benzinga | Sep. 17, 2014 | 09:28AM EST
  25. Gilead Sciences

    IBD | Sep. 16, 2014 | 18:53PM EST
  26. Stocks Rise Ahead Of Fed, Led By Biotech, Chip Names

    IBD | Sep. 16, 2014 | 17:01PM EST
  27. Gilead Up As Analyst Lifts Sovaldi Q3 Estimate

    IBD | Sep. 16, 2014 | 13:57PM EST
  28. Stock Futures Mildly Lower; Netflix, Gilead Still Sliding

    IBD | Sep. 16, 2014 | 09:09AM EST
  29. Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

    Benzinga | Sep. 16, 2014 | 08:19AM EST
  30. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 16, 2014 | 08:11AM EST
  31. Gilead to license Sovaldi

    IBD | Sep. 15, 2014 | 18:53PM EST
  32. Gilead OKs Generic Sovaldi To Expand Global Access

    IBD | Sep. 15, 2014 | 11:35AM EST
  33. Morning Market Losers

    Benzinga | Sep. 15, 2014 | 09:48AM EST
  34. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 15, 2014 | 08:15AM EST
  35. #PreMarket Primer: Monday, September 15: Cameron Vows To Destroy ISIS

    Benzinga | Sep. 15, 2014 | 07:54AM EST
  36. Mylan In Pact With Gilead To Accelerate Access To Hepatitis C

    Benzinga | Sep. 15, 2014 | 06:31AM EST
  37. Gilead, Jazz, Salix Among Top 6 IBD 50 Drugmakers

    IBD | Sep. 13, 2014 | 08:02AM EST
  38. 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 12, 2014 | 08:02AM EST
  39. Stocks Bounce As Nasdaq, S&P 500 Close With Small Gains

    IBD | Sep. 11, 2014 | 16:17PM EST
  40. Stocks Show Modest Losses; Biotechs Pressured Again

    IBD | Sep. 11, 2014 | 14:46PM EST
  41. Gilead Sciences, Inc. Could Be Taking A Break Before Even More Upside

    Benzinga | Sep. 10, 2014 | 15:05PM EST
  42. Stocks Turn Higher After Soft Start; U.S. Silica Jumps

    IBD | Sep. 10, 2014 | 13:25PM EST
  43. Stocks Up At Midday; Alexion Leads Biotech Rebound

    IBD | Sep. 10, 2014 | 11:54AM EST
  44. Under Armour, Apple, Gilead Among Big-Cap Leaders

    IBD | Sep. 10, 2014 | 08:02AM EST
  45. Pharmacyclics Price Target Cut On Higher Spending

    IBD | Sep. 8, 2014 | 13:02PM EST
  46. CNBC's Stock Pops & Drops From September 5

    Benzinga | Sep. 6, 2014 | 18:32PM EST
  47. CNBC's Stock Pops & Drops From September 5: Control4 Corp, Priceline Group Inc & More

    Benzinga | Sep. 6, 2014 | 18:32PM EST
  48. Allianz's Analyst Likes Biogen, Celgene & Gilead

    Benzinga | Sep. 6, 2014 | 17:28PM EST
  49. Fast Money Halftime Report Final Trade From September 5

    Benzinga | Sep. 6, 2014 | 17:26PM EST
  50. Meet 5 IBD 50 Stocks Expanding Into New Markets

    IBD | Sep. 6, 2014 | 08:01AM EST
Trading Center